https://www.bluelakebiotechnology.com/news daily 0.75 2026-03-06 https://www.bluelakebiotechnology.com/news/blue-lake-biotechnology-to-resume-enrollment-of-rsv-negative-toddlers-in-phase-12a-clinical-trial-of-blb201 monthly 0.5 2025-11-21 https://www.bluelakebiotechnology.com/news/blue-lake-and-cyanvac-publish-full-data-from-open-label-phase-1-clinical-study-of-covid-19-vaccine-candidate monthly 0.5 2025-11-21 https://www.bluelakebiotechnology.com/news/nasal-covid-vax-shows-promise-in-phase-1-clinical-trial monthly 0.5 2025-07-08 https://www.bluelakebiotechnology.com/news/preclinical-intranasal-covid-19-vaccine-candidate-data-demonstrate-durable-immune-response-and-broad-protection monthly 0.5 2025-07-08 https://www.bluelakebiotechnology.com/news/blue-lake-at-13th-international-rsv-symposium monthly 0.5 2025-03-11 https://www.bluelakebiotechnology.com/news/blue-lake-reports-additional-data-from-blb201-rsv-ph1-2 monthly 0.5 2024-12-12 https://www.bluelakebiotechnology.com/news/first-subject-dosed-in-initial-cohort-of-phase-2b-clinical-study-of-cyanvacs-intranasal-covid-19-vaccine-candidate monthly 0.5 2025-07-03 https://www.bluelakebiotechnology.com/news/blue-lake-and-cyanvac-report-positive-phase-2a-data-for-intranasal-covid-19-vaccine-candidate monthly 0.5 2024-11-25 https://www.bluelakebiotechnology.com/news/blue-lake-and-cyanvac-announce-presentation-at-isv monthly 0.5 2024-10-21 https://www.bluelakebiotechnology.com/news/cyanvac-receives-barda-award-for-covid-ph2b-study monthly 0.5 2025-07-08 https://www.bluelakebiotechnology.com/news/blue-lake-biotechnology-reports-positive-interim-clinical-data-innbspchildren-for-its-rsv-vaccine-candidatenbsp monthly 0.5 2025-07-08 https://www.bluelakebiotechnology.com/news/preclinical-data-on-piv5-based-intranasal-vaccine-against-lyme-disease-demonstrates-durable-immune-response monthly 0.5 2025-07-08 https://www.bluelakebiotechnology.com/news/6gwu38vycwr62ytvyzkcfewf2d1sx2 monthly 0.5 2025-07-08 https://www.bluelakebiotechnology.com/news/blue-lake-biotechnology-presenting-at-upcoming-biofuture-and-bio-investor-forum-conferences monthly 0.5 2024-02-15 https://www.bluelakebiotechnology.com/news/from-setbacks-to-solutions-pioneering-safe-rsv-vaccines-for-infants-children monthly 0.5 2023-10-02 https://www.bluelakebiotechnology.com/news/blue-lake-biotechnology-doses-first-child-in-clinical-trial-of-novel-intranasal-vaccine-against-respiratory-syncytial-virus monthly 0.5 2024-02-15 https://www.bluelakebiotechnology.com/news/blue-lake-biotechnology-to-be-featured-at-the-biotechnology-innovation-organization-bio-international-convention monthly 0.5 2024-02-15 https://www.bluelakebiotechnology.com/news/how-a-nasal-vaccine-could-reduce-the-risk-of-covid-infections-and-new-variants monthly 0.5 2023-03-21 https://www.bluelakebiotechnology.com/news/nasal-covid-vaccine-shows-promise-in-early-clinical-trial monthly 0.5 2023-02-24 https://www.bluelakebiotechnology.com/news/blue-lake-biotechnology-to-highlight-preliminary-covid-phase-1-data-at-bio-ceo-conference monthly 0.5 2024-02-15 https://www.bluelakebiotechnology.com/news/blue-lake-biotechnology-announces-positive-interim-phase-1-data-for-blb201-intranasal-rsv-vaccine-rnbjl monthly 0.5 2024-02-15 https://www.bluelakebiotechnology.com/news/fnbms5da3znqair6ux559cwerkyz7p-anje2 monthly 0.5 2023-02-24 https://www.bluelakebiotechnology.com/news/cyanvac-ceo-speaks-at-white-house-summit-on-the-future-of-covid-19-vaccines-39mah monthly 0.5 2023-01-04 https://www.bluelakebiotechnology.com/news/blue-lake-biotechnology-announces-first-participant-dosed-in-a-phase-1-clinical-trial-of-its-blb-201-intranasal-rsv-vaccine-dnw74 monthly 0.5 2023-01-04 https://www.bluelakebiotechnology.com/news/nasal-vaccines-are-commercially-high-risk-perhaps-high-reward-maxzl monthly 0.5 2023-02-24 https://www.bluelakebiotechnology.com/news/cyanvac-announces-data-from-preclinical-studies-of-intranasal-piv5-based-covid-19-vaccine-candidate-cvxga1-h2nah monthly 0.5 2022-06-10 https://www.bluelakebiotechnology.com/news/blue-lake-biotechnology-announces-fda-fast-track-designation-for-blb-201-intranasal-rsv-vaccine-ez8yx monthly 0.5 2024-02-15 https://www.bluelakebiotechnology.com/news/6agwredruwwesmxpwndfh6sqb2l98v-r49dn monthly 0.5 2023-02-24 https://www.bluelakebiotechnology.com/news/the-next-leap-in-coronavirus-vaccine-development-could-be-a-nasal-spray-a596p monthly 0.5 2023-02-24 https://www.bluelakebiotechnology.com/news/cyanvac-and-blue-lake-biotechnology-announce-fda-clearance-of-ind-application-for-blb-201-intranasal-rsv-vaccine-fd6ed monthly 0.5 2022-04-12 https://www.bluelakebiotechnology.com/news/cyanvac-and-blue-lake-biotechnology-announce-first-participant-dosed-in-aphase-1-clinical-trial-to-evaluate-its-cvxga1-intranasal-covid-19-vaccine-6pywz monthly 0.5 2022-07-19 https://www.bluelakebiotechnology.com/news/blog-post-title-one-592y5-ah9ad monthly 0.5 2024-08-22 https://www.bluelakebiotechnology.com/our-platform daily 0.75 2025-08-12 https://images.squarespace-cdn.com/content/v1/63a1f529ee02b44fed81fe94/1671702428170-606AZYB9KCUUMLOWQSH8/unsplash-image-At-LUvX6Eto.jpg https://images.squarespace-cdn.com/content/v1/63a1f529ee02b44fed81fe94/1671658012097-UPQ27OF0742UPHJQJ2Y7/unsplash-image-tGYrlchfObE.jpg https://www.bluelakebiotechnology.com/our-mission daily 1.0 2025-08-12 https://images.squarespace-cdn.com/content/v1/63a1f529ee02b44fed81fe94/1671558456919-U8SCWSB5T7T88RUIBPDU/IMG_7555.JPG https://www.bluelakebiotechnology.com/our-pipeline daily 0.75 2025-02-17 https://images.squarespace-cdn.com/content/v1/63a1f529ee02b44fed81fe94/ec0e979e-c1ca-41e8-beff-ad29969f90fc/Pipeline+2025-02.png https://images.squarespace-cdn.com/content/v1/63a1f529ee02b44fed81fe94/7856fa5c-9216-479f-94a0-3fe54ae20a18/CyanVac+PIV5+art+for+BLB+website+v2.jpg https://images.squarespace-cdn.com/content/v1/63a1f529ee02b44fed81fe94/4c03c390-f0e8-4ccd-884f-c8e6ad760723/Screenshot+2023-01-04+at+08.50.31.jpg https://images.squarespace-cdn.com/content/v1/63a1f529ee02b44fed81fe94/35f63492-451b-4059-bc6a-3901123a23ac/unsplash-image-gHAAa9U4a0k.jpg https://www.bluelakebiotechnology.com/our-team daily 0.75 2024-11-19 https://images.squarespace-cdn.com/content/v1/63a1f529ee02b44fed81fe94/2f2fbb7c-190c-4210-b3d1-c7cc3c35453b/Biao+He+IMG_6146+-+cropped.jpg Our Team https://images.squarespace-cdn.com/content/v1/63a1f529ee02b44fed81fe94/61ca9553-4721-475e-98cc-9d45452b5cfd/Gary+Titus+IMG_5843+-+cropped.jpg Our Team https://images.squarespace-cdn.com/content/v1/63a1f529ee02b44fed81fe94/3ed92543-25f5-46a9-8fc5-19aa19fdeea8/Hong+Jin+IMG_6012+-+cropped.jpg Our Team https://images.squarespace-cdn.com/content/v1/63a1f529ee02b44fed81fe94/26196747-3058-4633-ad07-5ccf46415f14/Samuel+Wu+IMG_6106+-+cropped.jpg Our Team https://images.squarespace-cdn.com/content/v1/63a1f529ee02b44fed81fe94/ea22e8d0-f74c-44c8-9319-dcb2860c9827/Hank+Radziewicz+IMG_6156+-+cropped.jpg Our Team https://images.squarespace-cdn.com/content/v1/63a1f529ee02b44fed81fe94/34c8b1b1-a626-40f6-91e2-998c9054d662/Marinka+Tellier+IMG_6197+-+cropped.jpg Our Team https://images.squarespace-cdn.com/content/v1/63a1f529ee02b44fed81fe94/ee509637-07c3-4ae9-b2d9-532b515903f3/Helen+Zhu+IMG_5985+-+cropped.jpg Our Team https://images.squarespace-cdn.com/content/v1/63a1f529ee02b44fed81fe94/1ef74db9-543a-4726-90e7-feb67ca13c4c/Barbara+Solow+2023-10-02+cropped+with+bkgd+replaced.jpg Our Team https://www.bluelakebiotechnology.com/contact daily 0.75 2025-08-14 https://www.bluelakebiotechnology.com/our-mission-1 daily 0.75 2023-04-25 https://images.squarespace-cdn.com/content/v1/63a1f529ee02b44fed81fe94/1671558456919-U8SCWSB5T7T88RUIBPDU/IMG_7555.JPG https://www.bluelakebiotechnology.com/research-associate daily 0.75 2025-03-31 https://www.bluelakebiotechnology.com/laboratory-assistant daily 0.75 2025-03-31 https://www.bluelakebiotechnology.com/hr-director daily 0.75 2025-03-31 https://www.bluelakebiotechnology.com/ra-san-jose-canceled daily 0.75 2025-03-31 https://www.bluelakebiotechnology.com/ra-athens daily 0.75 2025-03-31 https://www.bluelakebiotechnology.com/scientist-athens daily 0.75 2025-03-31